Carnegie acted as sole bookrunner in connection with Thor Medical ASA’s NOK 157.5 million private placement. In addition, the company has also completed a retail offering in Norway, Sweden, Finland and Denmark, raising approximately NOK 15 million.
Thor Medical is an emerging supplier of radionuclides, primarily alpha particle emitters, from naturally occurring thorium.